Get all your news in one place.
100's of premium titles.
One app.
Start reading
Axios
Axios
Health
Caitlin Owens

FDA moves forward on opioid "blister packs" to reduce number of prescribed pills

The FDA announced yesterday that it's requesting feedback on requiring certain opioids to be made available in "blister packs," which would include a limited number of pills.

How it works: The goal is to reduce the number of opioid pills prescribed, especially in situations when the typical 30-pill prescription is probably unnecessary.


  • The agency asked for feedback on which opioid medications make sense to be packaged this way, and what the appropriate number of pills to include in each pack is.

What they're saying: "Patients are often prescribed significantly more opioid pills than they actually use following surgical procedures or other acute pain conditions for which opioids are prescribed," acting FDA commissioner Ned Sharpless said.

  • "This excess supply of opioids provides opportunities for misuse, abuse, overdose and development of addiction."

Go deeper: The hot spots of the opioid epidemic

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.